| Symbol | CERS |
|---|---|
| Name | CERUS CORP |
| Sector | TECHNOLOGY |
| Region | UNDEFINED |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 1220 CONCORD AVENUE, CONCORD, CA 94520 |
| Telephone | 9252886000 |
| Fax | — |
| — | |
| Website | https://www.cerus.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same. Additional info from NASDAQ: |
📋 RICHARD J BENJAMIN (Officer) plans to sell 76K shares of CERUS CORPORATION (at $2.82 each, total $215K) Filed: May 01, 2026 | ID: 003893
Read more📋 VIVEK K JAYARAMAN (Officer) plans to sell 17K shares of CERUS CORPORATION (at $3.00 each, total $50K) Filed: May 01, 2026 | ID: 003891
Read moreCerus Corporation - Cerus Corporation Announces First Quarter 2026 Financial Results
Read moreCerus Corporation - Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
Read moreCerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
Read moreNew Form ARS - CERUS CORP <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001020214-26-000013 <b>Size:</b> 1 MB
Read moreNew Form DEF 14A - CERUS CORP <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001020214-26-000011 <b>Size:</b> 6 MB
Read moreCerus Corporation - Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
Read more